Form 4: Inari Medical CEO Andrew Hykes Reports Changes in Beneficial Ownership

Andrew Hykes, President and CEO of Inari Medical, reports the disposal of shares to cover tax obligations related to vesting restricted share units.

Summary

• On January 1, 2025, Andrew Hykes, the President and CEO of Inari Medical, Inc., reported changes in his beneficial ownership of the company's common stock.
• The transactions involved the disposal of shares to satisfy tax obligations related to the vesting of restricted share units awarded in 2021, 2022, 2023 and 2024.
• A total of 509, 949, 1,632 and 1,319 shares were disposed of at a price of $51.05 per share.
• Following these transactions, Hykes directly owns 434,901 shares of Inari Medical common stock.
• Hykes also indirectly owns 1,550 shares through Child 1, 1,550 shares through Child 2, 1,550 shares through Child 3 and 1,000 shares through his spouse.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions for tax purposes, with neutral sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the small number of shares involved.

Key Dates